2330 enters the new week with its domestic borrow market holding at elevated levels — and the question now is whether the jump in borrowing costs that was still accelerating on June 8 has found a ceiling, or is simply pausing.
The cost-to-borrow story remains the defining feature of this note. Domestic borrow costs on the TSEC listing have stabilised near 5.9% — up from 0.7% as recently as June 3, and from roughly 0.25% a month ago. That is an eightfold move in one month and a nearly tenfold move in under two weeks. As noted in the previous article published June 8, the borrow pressure migrated from the NYSE ADR to the domestic listing; that migration is now confirmed as persistent rather than a one-day anomaly. What makes the setup unusual is the contradiction with availability: lending pool availability remains effectively uncapped — the data reads at the platform ceiling of 9,999%, meaning shares to borrow are abundant. This is a cost-side dislocation, not a supply squeeze. Someone is paying sharply more to borrow 2330 even though borrow supply has not dried up, which points to directed demand — a specific trade or hedge — rather than a market-wide scramble for shares.
Short interest itself is negligible and does not tell an aggressive story. The borrowing fraction of the lending pool is under 0.4% — the highest reading in the 30-day window but still near the bottom of any meaningful short-interest range. The ORTEX short score runs at 25.4, placing the stock in the 96th percentile for low short-squeeze risk and consistent with an overall setup where speculative short pressure is minimal. The elevated borrow cost is therefore not a reflection of crowded positioning; it reflects the price of a specific borrowing transaction against a backdrop of very low baseline short interest.
The broader institutional picture is stable and incrementally positive. BlackRock added roughly 29.5 million shares in the most recent reporting period, and Capital Research added around 9.1 million. Those are not transformative moves for a stock with over 25 billion shares outstanding, but the direction of the largest active managers is constructive. The domestic sovereign anchor — Taiwan's National Development Fund — remains static at 6.4% with no change reported. Among insiders, the most notable recent print was a $14 million sale by Vice President Arthur Chuang on May 19, partially offset by token purchases from other officers. The net 90-day insider position is a small positive in share terms, though it is almost entirely explained by the differential sizing of those transactions. The Chuang sale is the more material signal of the two.
Valuation has drifted modestly higher over the past month. The trailing PE on the domestic shares runs near 21x, up marginally over 30 days. The EV/EBITDA multiple has eased slightly to roughly 13.8x. The factor score picture is largely unchanged from the prior note: the short-score rank at 96 confirms the near-absence of short pressure, while the EV/EBIT rank at 79 reflects above-average but not extreme valuation relative to the universe. Analyst data on the TSEC listing is too dated to cite — last coverage data is from 2021. For current Street consensus, the NYSE ADR TSM remains the better reference, where the prior note noted a consensus target near $468 against an ADR price that was recovering from its June 5 selloff.
The domestic share price has stabilised since the selloff, closing at TWD 2,305 on June 9, up 0.4% on the day but still 3.2% lower on the week. With Q2 results due July 16, the next few weeks will test whether the borrow-cost spike was a positioning artefact ahead of that event — or something more structural. The key signal to track is whether domestic borrow costs ease back toward their sub-1% May baseline as the date approaches, or hold at current levels and confirm that directed hedging demand is becoming a recurring feature of the listing.
See the live data behind this article on ORTEX.
Open 2330 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
